Your browser doesn't support javascript.
loading
Multiple tyrosine kinase inhibitors before allogeneic stem cell transplantation for chronic myeloid leukemia: toxicity and efficacy in a single-center experience.
Helbig, Grzegorz; Duda, Katarzyna; Krzemien, Helena; Wlodarczyk, Martyna; Kata, Dariusz; Wieczorkiewicz-Kabut, Agata.
Affiliation
  • Helbig G; Department of Hematology and Bone Marrow Transplantation, School of Medicine in Katowice, Medical University of Silesia, Katowice, Poland. ghelbig@o2.pl
  • Duda K; Department of Hematology and Bone Marrow Transplantation, School of Medicine in Katowice, Medical University of Silesia, Katowice, Poland
  • Krzemien H; Department of Hematology and Bone Marrow Transplantation, School of Medicine in Katowice, Medical University of Silesia, Katowice, Poland
  • Wlodarczyk M; Department of Hematology and Bone Marrow Transplantation, School of Medicine in Katowice, Medical University of Silesia, Katowice, Poland
  • Kata D; Department of Hematology and Bone Marrow Transplantation, School of Medicine in Katowice, Medical University of Silesia, Katowice, Poland
  • Wieczorkiewicz-Kabut A; Department of Hematology and Bone Marrow Transplantation, School of Medicine in Katowice, Medical University of Silesia, Katowice, Poland
Pol Arch Intern Med ; 130(6): 553-556, 2020 06 25.
Article in En | MEDLINE | ID: mdl-32388967

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Hematopoietic Stem Cell Transplantation Limits: Humans Language: En Journal: Pol Arch Intern Med Year: 2020 Document type: Article Affiliation country: Poland

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Hematopoietic Stem Cell Transplantation Limits: Humans Language: En Journal: Pol Arch Intern Med Year: 2020 Document type: Article Affiliation country: Poland